Search

everythinglearnresearchcommunity

for

Search:↓

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Achieving 80% or more scalp hair regrowth is considered a successful treatment for significant hair loss.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

Minoxidil-dutasteride tattooing can potentially help regrow hair, especially in men who already have some thin hair.

Low vitamin D might be one of several factors involved in the hair loss condition alopecia areata.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.

Genetic testing for EGFR mutations is crucial in similar cases.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

A patient with congenital adrenal hyperplasia improved after adjusting her medication to prevent Cushing's syndrome symptoms.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Microneedling with Triamcinolone acetonide is an effective, less invasive, and safe alternative to direct injections for treating alopecia areata.

Different conditions affect how hair proteins assemble, and certain mutations can change their structure.

Topical tofacitinib is effective and safe for treating alopecia areata.

The SbbHLH85 protein helps sweet sorghum grow more root hairs but makes the plant more sensitive to salt.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

Researchers created a fast, accurate computer program to measure hair loss in alopecia areata patients.

Higher levels of PD-L1 are linked to more severe hair loss in people with Alopecia Areata.

Baricitinib treatment for severe alopecia areata shows significant improvement by 52 weeks, especially in very severe cases.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Corin helps control salt and sweat release in sweat glands.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.